Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-058703

Chief Financial Officer sold 50,000 shares at an average $7.49 ($374,638)

  • Chief Financial Officer acquired 75,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Secora Michael · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-12 Exercise or conversion : show line 1 in the form 10b5-1 +37,500 $2.22 $83,250 968,514 D
2023-12-12 Sale : show line 2 in the form 10b5-1 −25,000 $7.39 $184,868 943,514 D
2023-12-13 Exercise or conversion : show line 3 in the form 10b5-1 +37,500 $2.22 $83,250 981,014 D
2023-12-13 Sale : show line 4 in the form 10b5-1 −25,000 $7.59 $189,770 956,014 D
Open-market sales · 50,000 sh · avg $7.49 · $374,638

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-12-12 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −37,500 $2.22 2030-03-03 37,500 1,147,635 D
2023-12-13 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −37,500 $2.22 2030-03-03 37,500 1,110,135 D
Loading xslF345X05/doc4.xml…